These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome. Mirza S; Hill E; Ludlow SP; Nanjappa S Melanoma Res; 2017 Jun; 27(3):271-273. PubMed ID: 28146044 [TBL] [Abstract][Full Text] [Related]
17. Eosinophilic fasciitis following exposure to trichloroethylene: successful treatment with cyclosporin. Hayashi N; Igarashi A; Matsuyama T; Harada S Br J Dermatol; 2000 Apr; 142(4):830-2. PubMed ID: 10792252 [No Abstract] [Full Text] [Related]
18. An Original Case of an Association of Eosinophilic Fasciitis with Cholangitis Induced by Nivolumab. Le Tallec E; Ricordel C; Triquet L; Deniel A; Marcorelles P; Lena H; Jego P; Belhomme N J Thorac Oncol; 2019 Jan; 14(1):e13-e15. PubMed ID: 30579548 [No Abstract] [Full Text] [Related]
19. Eosinophilic fasciitis associated with tryptophan ingestion. A manifestation of eosinophilia-myalgia syndrome. Gordon ML; Lebwohl MG; Phelps RG; Cohen SR; Fleischmajer R Arch Dermatol; 1991 Feb; 127(2):217-20. PubMed ID: 1990986 [TBL] [Abstract][Full Text] [Related]
20. Association of L-tryptophan and an illness resembling eosinophilic fasciitis. Clinical and histopathologic findings in four patients with eosinophilia-myalgia syndrome. Bulpitt KJ; Verity MA; Clements PJ; Paulus HE Arthritis Rheum; 1990 Jul; 33(7):918-29. PubMed ID: 2369428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]